查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591901

人源化小鼠和大鼠模型市場：按類型、應用和最終用戶分類 - 全球預測 2025-2030

Humanized Mouse & Rat Model Market by Type (Humanized Mouse Model, Humanized Rat Model), Application (Hematopoiesis, Immunology & Infectious Diseases, Neuroscience), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，人源化小鼠和大鼠模型市值為2.5738億美元，預計2024年將達到2.7591億美元，複合年成長率為7.33%，2030年將達到4.2257億美元，預計將達到1000萬美元。

人源化小鼠和大鼠模型市場是生物醫學研究的重要領域，旨在開拓和測試複雜人類疾病的可行治療策略。該領域包括攜帶人類基因、組織和細胞並提供適應人類生物和病理現象的體內模型的基因工程囓齒動物。對此類模型的需求與理解疾病機制、藥物發現和個人化醫療密切相關，並擴展到腫瘤學、免疫學和感染疾病中的應用。最終用途領域多種多樣，包括學術和研究機構、製藥和生物技術公司以及合約研究組織。

主要市場統計
基準年[2023] 2.5738億美元
預測年份 [2024] 27591萬美元
預測年份 [2030] 4.2257 億美元
複合年成長率（%） 7.33%

關鍵的成長要素包括慢性病盛行率的不斷上升、對新型治療解決方案的緊迫性以及促進模型開發的基因組技術的進步。同時，道德問題和高成本為市場擴張帶來了挑戰。 CRISPR 和其他基因編輯技術的持續創新有可能減少開發時間和成本，同時提高基因人源化的精確度，使公司能夠更自信地進行藥物測試。然而，市場相關人員必須遵守嚴格的法律規範，並克服與囓齒動物複雜的遺傳和免疫特徵人性化相關的技術障礙。

一種創新方法是透過多基因人源化來完善模型並整合人類免疫學成分，以提高我們對人類對治療的獨特反應的了解。學術、臨床和工業部門之間的合作和協同效應將加強建模平台並加速轉化研究。對於市場參與企業來說，策略重點是建立更全面和高度專業化的人性化模型組合可以釋放競爭優勢。此外，透過參與利用人工智慧和計算模型的夥伴關係，我們可以徹底改變預測分析並最大限度地提高模型在藥物發現中的效用。

總之，雖然存在有希望的機會，但相關人員可以透過利用技術進步、策略聯盟和緩解生物醫學研究中的常見瓶頸來確保市場的持續成長，從而需要滿足對有效人類翻譯系統日益成長的需求。

市場動態：快速發展的人源化小鼠和大鼠模型市場的關鍵市場洞察

人性化小鼠和大鼠模型市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 增加生物醫學研究和藥物開發活動
    • 日益關注個人化醫療和精準治療
    • 由於監管要求和道德考慮，需求增加
  • 市場限制因素
    • 人源化小鼠和大鼠的複雜模型開發和檢驗過程
  • 市場機會
    • 基因工程技術的進展
    • 人源化小鼠和大鼠模型與人類類器官和有機晶片技術的整合
  • 市場挑戰
    • 再現人類生理學的局限性

波特五力：駕馭人性化小鼠和大鼠模型市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解人源化小鼠和大鼠模型市場的外部影響

外部宏觀環境因素在塑造人源化小鼠和大鼠模型市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解人源化小鼠和大鼠模型市場的競爭狀況

對人源化小鼠和大鼠模型市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣人源化小鼠及大鼠模型市場廠商績效評估

FPNV定位矩陣是評估人源化小鼠和大鼠模型市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了人源化小鼠和大鼠模型市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，人源化小鼠和大鼠模型市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加生物醫學研究和藥物開發活動
      • 日益關注個人化醫療和精準治療
      • 由於監管要求和道德考慮，需求不斷成長
    • 抑制因素
      • 人源化小鼠和大鼠的複雜模型開發和檢驗過程
    • 機會
      • 基因工程技術的進展
      • 將人類類器官和器官晶片技術與人源化小鼠和大鼠模型結合
    • 任務
      • 再現人類生理學的局限性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章人源化小鼠和大鼠模型市場：依類型

  • 人源化小鼠模型
    • BLT模型
    • Hu-PBL-scid模型
    • Hu-SRC-scid模型
  • 人源化大鼠模型

第7章人源化小鼠與大鼠模型市場：依應用分類

  • 造血作用
  • 免疫學和感染疾病
  • 神經科學
  • 腫瘤學
  • 毒理學

第8章人源化小鼠和大鼠模型市場：依最終使用者分類

  • 學術研究設施
  • 合約研究和製造組織
  • 製藥和生物技術公司

第9章北美和南美人源化小鼠和大鼠模型市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區人源化小鼠與大鼠模型市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲人源化小鼠及大鼠模型市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Aragen Life Sciences
  • Beijing Vitalstar Biotechnology Co., Ltd.
  • BIOCYTOGEN
  • Champions Oncology, Inc.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Cyagen US Inc.
  • GemPharmatech
  • genOway
  • Harbour BioMed
  • Hera BioLabs
  • inGenious Targeting Laboratory, Inc.
  • Oncodesign Precision Medicine
  • Ozgene Pty Ltd.
  • Pharmatest Services Oy
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory
  • TransCure Bioservices
  • Vivo Bio Tech Ltd.
Product Code: MRR-961BA04A2E3A

The Humanized Mouse & Rat Model Market was valued at USD 257.38 million in 2023, expected to reach USD 275.91 million in 2024, and is projected to grow at a CAGR of 7.33%, to USD 422.57 million by 2030.

The humanized mouse and rat model market is an integral segment of biomedical research, geared towards developing and testing viable therapeutic strategies for complex human diseases. This scope encompasses genetically engineered rodents that carry functioning human genes, tissues, or cells, providing an in-vivo model conforming to human biological and pathological phenomena. The necessity for these models is profound in understanding disease mechanisms, drug discovery, and personalized medicine, extending to applications in oncology, immunology, and infectious diseases. End-use domains stretch across academic and research institutions, pharmaceutical and biotechnology companies, and contract research organizations.

KEY MARKET STATISTICS
Base Year [2023] USD 257.38 million
Estimated Year [2024] USD 275.91 million
Forecast Year [2030] USD 422.57 million
CAGR (%) 7.33%

Key growth factors include the increasing prevalence of chronic diseases, the urgency for novel therapeutic solutions, and advancing genomic technologies enhancing model development. Simultaneously, ethical concerns and high costs challenge market expansion. Opportunities arise from ongoing innovations in CRISPR and other gene-editing technologies, which potentially reduce development times and costs while increasing the precision of genetic humanization, allowing organizations to advance drug testing with higher reliability. However, market players must navigate stringent regulatory frameworks and overcome technical hurdles associated with humanizing complex genetic and immunological traits of rodents.

Innovations lie in enhancing model sophistication through multi-gene humanization and integrating human immune components, offering improved insights into human-specific responses to therapies. Collaborative synergies among academic, clinical, and industrial sectors would catalyze enhanced model platforms, accelerating translational research. For market players, a strategic focus on building portfolios of more comprehensive and highly specialized humanized models can unlock competitive advantages. Additionally, participating in partnerships leveraging AI and computational models could revolutionize predictive analytics, thus maximizing model utility in drug discovery.

In conclusion, while promising opportunities exist, stakeholders must leverage technological advancements and strategic collaborations to mitigate prevailing obstacles, thus ensuring sustained market growth and fulfilling the growing demand for effective human translational systems in biomedical research.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Humanized Mouse & Rat Model Market

The Humanized Mouse & Rat Model Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of biomedical research and drug development activities
    • Emerging focus toward personalized medicine and precision therapeutics
    • Rising demand owing to regulatory requirements and ethical considerations
  • Market Restraints
    • Complex model development and validation process of humanized mouse & rats
  • Market Opportunities
    • Growing advancements in genetic engineering technologies
    • Integration of human organoids and organ-on-a-chip technologies with humanized mouse and rat models
  • Market Challenges
    • Limitations in recapitulating human physiology

Porter's Five Forces: A Strategic Tool for Navigating the Humanized Mouse & Rat Model Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Humanized Mouse & Rat Model Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Humanized Mouse & Rat Model Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Humanized Mouse & Rat Model Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Humanized Mouse & Rat Model Market

A detailed market share analysis in the Humanized Mouse & Rat Model Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Humanized Mouse & Rat Model Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Humanized Mouse & Rat Model Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Humanized Mouse & Rat Model Market

A strategic analysis of the Humanized Mouse & Rat Model Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Humanized Mouse & Rat Model Market, highlighting leading vendors and their innovative profiles. These include Aragen Life Sciences, Beijing Vitalstar Biotechnology Co., Ltd., BIOCYTOGEN, Champions Oncology, Inc., Charles River Laboratories International, Inc., Crown Bioscience, Inc., Cyagen US Inc., GemPharmatech, genOway, Harbour BioMed, Hera BioLabs, inGenious Targeting Laboratory, Inc., Oncodesign Precision Medicine, Ozgene Pty Ltd., Pharmatest Services Oy, Taconic Biosciences, Inc., The Jackson Laboratory, TransCure Bioservices, and Vivo Bio Tech Ltd..

Market Segmentation & Coverage

This research report categorizes the Humanized Mouse & Rat Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Humanized Mouse Model and Humanized Rat Model. The Humanized Mouse Model is further studied across BLT Model, Hu-PBL-scid Model, and Hu-SRC-scid Model.
  • Based on Application, market is studied across Hematopoiesis, Immunology & Infectious Diseases, Neuroscience, Oncology, and Toxicology.
  • Based on End-User, market is studied across Academic & Research Facilities, Contract research & Manufacturing Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of biomedical research and drug development activities
      • 5.1.1.2. Emerging focus toward personalized medicine and precision therapeutics
      • 5.1.1.3. Rising demand owing to regulatory requirements and ethical considerations
    • 5.1.2. Restraints
      • 5.1.2.1. Complex model development and validation process of humanized mouse & rats
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing advancements in genetic engineering technologies
      • 5.1.3.2. Integration of human organoids and organ-on-a-chip technologies with humanized mouse and rat models
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations in recapitulating human physiology
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Humanized Mouse & Rat Model Market, by Type

  • 6.1. Introduction
  • 6.2. Humanized Mouse Model
    • 6.2.1. BLT Model
    • 6.2.2. Hu-PBL-scid Model
    • 6.2.3. Hu-SRC-scid Model
  • 6.3. Humanized Rat Model

7. Humanized Mouse & Rat Model Market, by Application

  • 7.1. Introduction
  • 7.2. Hematopoiesis
  • 7.3. Immunology & Infectious Diseases
  • 7.4. Neuroscience
  • 7.5. Oncology
  • 7.6. Toxicology

8. Humanized Mouse & Rat Model Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Facilities
  • 8.3. Contract research & Manufacturing Organizations
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Humanized Mouse & Rat Model Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Humanized Mouse & Rat Model Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Humanized Mouse & Rat Model Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aragen Life Sciences
  • 2. Beijing Vitalstar Biotechnology Co., Ltd.
  • 3. BIOCYTOGEN
  • 4. Champions Oncology, Inc.
  • 5. Charles River Laboratories International, Inc.
  • 6. Crown Bioscience, Inc.
  • 7. Cyagen US Inc.
  • 8. GemPharmatech
  • 9. genOway
  • 10. Harbour BioMed
  • 11. Hera BioLabs
  • 12. inGenious Targeting Laboratory, Inc.
  • 13. Oncodesign Precision Medicine
  • 14. Ozgene Pty Ltd.
  • 15. Pharmatest Services Oy
  • 16. Taconic Biosciences, Inc.
  • 17. The Jackson Laboratory
  • 18. TransCure Bioservices
  • 19. Vivo Bio Tech Ltd.

LIST OF FIGURES

  • FIGURE 1. HUMANIZED MOUSE & RAT MODEL MARKET RESEARCH PROCESS
  • FIGURE 2. HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HUMANIZED MOUSE & RAT MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HUMANIZED MOUSE & RAT MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMANIZED MOUSE & RAT MODEL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HUMANIZED MOUSE & RAT MODEL MARKET DYNAMICS
  • TABLE 7. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY BLT MODEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HU-PBL-SCID MODEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HU-SRC-SCID MODEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HEMATOPOIESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY & INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROSCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ACADEMIC & RESEARCH FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. HUMANIZED MOUSE & RAT MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. HUMANIZED MOUSE & RAT MODEL MARKET, FPNV POSITIONING MATRIX, 2023